ATIF Holdings Ltd AUC
are a British Virgin Islands business company. We are a business consulting company providing financial consulting services
to small and medium-sized enterprises ("SMEs") and prior to August 1, 2022, our Affiliated Entity ATIF USA, managed a private
equity fund with approximately $1.3 million assets under management ("AUM"). Since our inception in 2015, the main focus of
our consulting business has been providing comprehensive going public consulting services designed to help SMEs become public companies
Valuation FY2024 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.0K | $20.8K | $20.8K | $2.4M | $6.3M | $400.0K | $5.3M | $3.6M | — |
| Cost of revenue | — | — | $660.0K | — | $227.4K | — | — | — | — |
| Gross profit | — | $2.5M | $1.0M | $936.9K | $458.6K | $3.1M | $5.3M | — | — |
| SG&A | $2.3M | $2.2M | $2.7M | $2.9M | $3.1M | $1.2M | $807.1K | $408.7K | — |
| Total operating expenses | $2.6M | $3.2M | $3.2M | $3.4M | $7.0M | $2.4M | $2.6M | $2.7M | — |
| Operating income | -$2.0M | -$760.9K | -$2.2M | -$2.4M | -$6.4M | $671.6K | $2.7M | $925.1K | — |
| Interest expense | $26 | $1.9K | — | — | — | — | — | — | — |
| Pre-tax income | -$3.2M | -$2.9M | -$3.4M | -$2.4M | -$6.3M | $706.0K | $2.7M | $858.0K | — |
| Income tax | $3.3K | $31.2K | — | — | $76.3K | $276.8K | $716.8K | $217.0K | — |
| Net income | -$3.2M | -$2.9M | -$2.9M | -$9.0M | -$17.3M | $429.2K | $1.9M | $641.0K | — |
| EPS, basic | -0.31 | -0.30 | -0.31 | -0.90 | — | — | — | — | — |
| EPS, diluted | -0.31 | -0.30 | -0.31 | -0.90 | -1.87 | 0.06 | 0.06 | 0.02 | — |
| Shares, diluted (wtd. avg.) | 10.2M | 9.6M | 9.5M | 9.5M | — | — | — | — | — |
Balance sheet
| Fiscal year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.2M | $606.0K | $1.8M | $5.6M | $409.7K | $6.5M | $73.0K | $144.8K | $9.9K |
| Short-term investments | $424.1K | $130.6K | — | — | — | — | — | — | — |
| Receivables | — | $650.0K | — | $1.0M | $939.4K | $1.5M | $137.6K | — | — |
| Inventory | — | — | — | — | $46.8K | — | — | — | — |
| Total current assets | $2.9M | $2.5M | $6.0M | $9.8M | $5.2M | $10.6M | $3.7M | — | — |
| Property, plant and equipment | $60.0K | $93.6K | $272.7K | $572.0K | $606.2K | $49.0K | $49.4K | — | — |
| Goodwill | — | — | — | — | $25.9M | $0 | — | — | — |
| Other intangibles | — | $73.3K | $153.3K | $233.3K | $330.5K | $428.8K | — | — | — |
| Total assets | $3.0M | $3.8M | $8.1M | $11.4M | $45.8M | $12.3M | $3.7M | — | — |
| Accounts payable | $957.1K | $293.1K | $2.3M | $482 | $482 | — | — | — | — |
| Total current liabilities | $988.4K | $1.5M | $2.8M | $1.3M | $7.8M | $1.1M | $1.7M | — | — |
| Total liabilities | $1.3M | $2.2M | $3.8M | $1.7M | $11.2M | $1.1M | — | — | — |
| Retained earnings | -$30.9M | -$27.7M | -$24.8M | -$22.1M | -$13.5M | $1.4M | $1.0M | — | — |
| Total equity | $1.8M | $1.5M | $4.4M | $9.7M | $34.6M | $11.2M | $2.0M | -$574.1K | -$1.3M |
Cash flow
| Fiscal year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$120.5K | -$2.3M | -$146.9K | -$2.7M | -$5.9M | -$3.0M | $2.0M | $153.7K | — |
| Depreciation and amortisation | $112.0K | $138.8K | $158.6K | $209.0K | $120.7K | $50.3K | $16.5K | $11.3K | — |
| Capital expenditure | $5.1K | $1.4K | $102.0K | $106.5K | $874.4K | $20.8K | $26.8K | $15.0K | — |
| Investing cash flow | -$1.6M | $459.8K | -$1.6M | $861.9K | -$176.5K | $739.1K | -$2.9M | -$20.5K | — |
| Financing cash flow | $2.3M | $730.0K | -$2.0M | $6.8M | $142.0K | $8.7M | $755.1K | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-24-097579.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $3.6M | $5.3M | $400.0K | $6.3M | $2.4M | $20.8K | $20.8K | $70.0K |
| Gross profit | — | — | $5.3M | $3.1M | $458.6K | $936.9K | $1.0M | $2.5M | — |
| Net income | — | $641.0K | $1.9M | $429.2K | -$17.3M | -$9.0M | -$2.9M | -$2.9M | -$3.2M |
Recent filings and events
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Officer or director change Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed Item 1.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Officer or director change Item 5.02
- Other event Item 8.01
- Material agreement signed Item 1.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |